Treatment as Prevention¨

Injectable PrEP and other options are in the pipeline, and that makes clinical trials more complicated A clinical trial set to begin later this year will test whether an experimental drug injected every two months protects against HIV infection as effectively as a once-a-day pill called Truvada. If it does, the long-acting PrEP drug – […]

Later this month, NAM will be reporting from two international HIV conferences – HIV Research for Prevention (HIVR4P) and the International Congress on Drug Therapy in HIV Infection (HIV Glasgow). HIVR4P HIVR4P is being held in Chicago, USA from 17-21 October. The conference is dedicated to biomedical HIV prevention research, including vaccines, microbicides, pre-exposure prophylaxis

The 90-90-90 targets for HIV will dominate discussion at the upcoming Controlling the HIV Epidemic with Antiretrovirals Summit 2016 in Geneva. “When we launched this series of summits several years ago, we did not have consensus on the importance of scaling up treatment as prevention and pre-exposure prophylaxis,” said JosŽ Zuniga, PhD, president of the

En la octava edición, el infectólogo Julio Montaner fue galardonado con el premio Perfil En la octava edición de estos galardones, el infectólogo Julio Montaner fue galardonado con el premio Perfil a la Inteligencia de los argentinos, categoría Ciencia y Tecnología. Su trabajo fue clave para descubrir que un cóctel de tres drogas podía controlar

El joven Gino Tubaro fue uno de los más aplaudidos y hubo un homenaje para el fotógrafo asesinado JosŽ Luis Cabezas. En su discurso, el CEO de la editorial, Jorge Fontevecchia, dijo que el kirchnerismo es “una estructura mítico-religiosa” En una ceremonia que contó con la presencia de políticos, periodistas e intelectuales, la editorial Perfil

It has been 35 years since the first case of HIV/AIDS was recorded in Connecticut, and since then, Yale has been at the forefront of scientific interventions to address the challenges posed by the epidemic. Elaine O’Keefe, who currently serves as the executive director for Yale’s Center for Interdisciplinary Research on AIDS, was one of

Picture this scenario: An individual living with HIV in British Columbia, “Doug” (whose name has been changed for privacy), was being “shuffled around” through care. As a result, he had grown tired and had mostly given up on treating his HIV. Sadly, he had begun telling family and friends that he wouldn’t be around much

The UNAIDS Prevention gap report shows that HIV prevention efforts must be reinvigorated if the world is to stay on the Fast-Track to ending the AIDS epidemic by 2030. To achieve the global Fast-Track Target of reducing the number of new HIV infections to fewer than 500 000 by 2020, more political commitment and increased

When I have anal sex, I’m always a top, and I usually use condoms, even after being on Truvada (tenofovir/FTC) for two years. There are several reasons for this, but HIV isn’t one. PrEP (pre-exposure prophylaxis) and, just as important, treatment as prevention (TasP) and the undetectable status have freed me from concerns about contracting